KDM2A Deficiency in the Liver Promotes Abnormal Liver Function and Potential Liver Damage

Area of Science:

• Metabolic regulation
• Liver physiology
• Inflammation pathways

Background:

• Liver metabolic dysfunction is linked to diabetes and metabolic disorders.
• Nuclear factor-kappa B (NF-κB) signaling activation drives liver inflammation.
• Lysine demethylase 2A (KDM2A) is a known negative regulator of NF-κB.

Purpose of the Study:

• To investigate the role of KDM2A in liver function.
• To establish and utilize a novel liver-specific KDM2A knockout mouse model.

Main Methods:

• Generated an inducible liver-specific KDM2A knockout mouse model (Alb-Cre-Kdm2a).
• Analyzed liver function markers (ALT, triglycerides, glycogen) under normal and high-fat diet (HFD) conditions.
• Assessed NF-κB target gene expression and immune cell infiltration.

Main Results:

• KDM2A knockout mice showed elevated ALT, triglycerides, and liver glycogen levels.
• These metabolic alterations were exacerbated under HFD.
• Increased NF-κB target gene expression and immune cell infiltration were observed in knockout mice.

Conclusions:

• Liver-specific KDM2A deficiency promotes liver inflammation, potentially via NF-κB activation.
• KDM2A deficiency leads to liver dysfunction and metabolic abnormalities.
• The developed KDM2A knockout mouse model is valuable for studying liver metabolic diseases.